Who founded AssayQuant Technologies?

AssayQuant Technologies was founded by Erik Schaefer.

How much funding has AssayQuant Technologies raised?

AssayQuant Technologies has disclosed $9.6M raised across 2 rounds.

Where is AssayQuant Technologies headquartered?

AssayQuant Technologies is headquartered in Marlboro, US.

AssayQuant Technologies

Marlboro, US · Delaware corporation

AssayQuant develops PhosphoSens fluorescent sensor peptide substrates and assay kits that measure kinase and phosphatase activity in real time, along with KinSight lab services for compound potency, selectivity, and mechanism-of-inhibition profiling. Its products and services serve preclinical drug discovery teams working on kinase and phosphatase inhibitors, covering over 500 kinase and 35 phosphatase targets.</parameter> <parameter name="sector_codes">["biotech", "deeptech"]

Biotech

Founders & leadership

Erik SchaeferinFounder

Barbara ImperialiNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$9.6M disclosed across 2 rounds · 2021–2023

▶$5.1MraisedJul 2023 · 21 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

Barbara ImperialiDirector
Gil PriceDirector
Jeffrey HoerleDirector
Erik SchaeferExecutive Officer
Charles BalticDirector

Offering amount: $12M
Amount sold: $5.1M
First sale: Jul 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

▶$4.5MraisedMay 2021 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Erik SchaeferExecutive Officer
Barbara ImperialiDirector

Offering amount: $4.5M
Amount sold: $4.5M
First sale: May 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

BellBrook Labs9 shared keywordsBellBrook Labs supplies life-science research products and services to laboratories, distributed internationally through regional partners across Europe, Asia, and Oceania. Its offerings serve the biotechnology and drug-discovery research market.

Molecular Devices7 shared keywordsMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.

Companies competing with AssayQuant Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does AssayQuant Technologies do?: AssayQuant develops PhosphoSens fluorescent sensor peptide substrates and assay kits that measure kinase and phosphatase activity in real time, along with KinSight lab services for compound potency, selectivity, and mechanism-of-inhibition profiling. Its products and services serve preclinical drug discovery teams working on kinase and phosphatase inhibitors, covering over 500 kinase and 35 phosphatase targets.</parameter> <parameter name="sector_codes">["biotech", "deeptech"]
Who founded AssayQuant Technologies?: AssayQuant Technologies was founded by Erik Schaefer.
How much funding has AssayQuant Technologies raised?: AssayQuant Technologies has disclosed $9.6M raised across 2 rounds.
Where is AssayQuant Technologies headquartered?: AssayQuant Technologies is headquartered in Marlboro, US.